- News |
-
- Featured
-
Canada’s privacy commissioner launches investigation over the use..
As the years pass by, technology also widens, and more and more are being discovered. From simple gadgets..
- Business |
-
- Featured
-
Be an informer to I-T dept; earn up..
Sharing "specific information" with the income tax department about any benami..
- Tech & Industry |
-
- Featured
-
Gravitational wave event likely signaled birth of black..
The merger of two neutron stars that generated gravitational waves detected last year may have led to the birth..
- Entertainment |
-
- Topics
- Malayalam Film
- Media
- Music
- Youth
-
- Featured
-
Shawn Mendes Released Highly Anticipated Self-Titled Album Today
Los Angeles, CA : Multi-Platinum singer/songwriter Shawn Mendes released his highly anticipated self-titled third album today, via Island Records. Get..
-
- New Products |
-
- Topics
- General
-
- Featured
-
ZOTAC Introduces Its GeForce GTX 960 series graphics..
Dubai- ZOTAC International, a leading innovator and manufacturer of graphic cards and mini-
-
- Education |
-
- Topics
- Campus News
-
- Featured
-
ITM University, Gurgaon Student Palash Chhabra Represents Varsity..
New Delhi: Palash Chhabra, a student of ITM University,..
-
- Health |
-
- Topics
- Medical News
-
- Featured
-
Maharshi Shushruta, The Great Grandfather of Surgery!
by Ayurvedacharya Dr.Hitesh Jani Dr.Hitesh Jani
-
- Tourism |
-
- Topics
- Travel
- Food&Beverages
- Hospitality
-
- Featured
-
“Keraliya Ayurveda is Credible and Authentic”
Irina Gurjeva Irina Gurjeva is not just another vacationer in..
-
- Sports |
- Editor's column |
- Magazine |
Serum Institute of India applies for emergency approval of covid vaccine candidate ‘Covishield’
Published on December 7, 2020
Serum Institute of India (SII) has applied for emergency approval of made-in-India covid vaccine candidate, Covishield. SII CEO Adar Poonawalla has confirmed it and said it will save countless lives.
He also thanked the Government of India and Prime minister Narendra Modi for their invaluable support. SII, the world’s largest vaccine producer by volume, had sought emergency use authorization in the country for AstraZeneca Plc’s COVID-19 vaccine candidate.
The company applied to the Drugs Controller General of India, citing unmet medical needs due to the pandemic and in the interest of the public at large. The move comes close on the heels of Pfizer Inc applying for a similar authorization of its coronavirus vaccine in India.
